Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
Clinical trial NCT02054351 · COMPLETED
Trial details
- NCT number
- NCT02054351
- Sponsor
- Ganymed Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-06
- Primary completion
- 2015-10-28
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.